|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2101 Batch: A210126
Anti-mouse CD4 antibody(Clone:GK1.5) reacts with mouse CD4, which is a 55 kDa cell surface type I membrane glycoprotein. CD4 is a co-receptor of the T cell receptor (TCR) and assists the latter in communicating with antigen-presenting cells.
| Formulation | PBS buffer, pH 6.5 |
|---|---|
| Clone | GK1.5 |
| Immunogen | Mouse CTL clone V4 |
| Isotype | Rat IgG2b,κ |
| Application | In vivo CD4+ T cell depletion,FCM,WB |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| Shipping | Shipped under low temperature conditions |
| Sterility | 0.2 μM filtered |
| Purity | 99% |
| Protein concentration | 7.45 mg/ml |
| Endotoxin Level | <1EU/mg |




| HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 30, 2026, e014185] | PubMed: 41912269 |
| Cryoablation Activates the cGAS-STING-CXCL10 Axis in Macrophages to Enhance Anti-Tumor Immunity in NSCLC [ Advanced Science, March 12, 2026, e21931] | PubMed: 41818612 |
| HFB301001, an OX40-based immunotherapy, drives Treg clearance and CTL activation through optimized OX40 receptor clustering [ Journal for ImmunoTherapy of Cancer, March 1, 2026, e014185] | PubMed: 41912269 |
| DADA Enhances CD8+ T Cell Stemness to Improve Anti‐Tumor Immunity and Immunotherapy Efficacy [ Advanced Science, February 27, 2026, e19765] | PubMed: 41758776 |
| Oncolytic adenovirus delivery of neoantigens sensitizes low-mutation tumors to anti-PD-1 therapy and prevents metastasis [ Signal Transduction and Targeted Therapy, December 23, 2025, 410] | PubMed: 41429778 |
| Anti-BCL2 therapy eliminates giant congenital melanocytic nevus by senolytic and immune induction [ Signal Transduct Target Ther, 2025, 10(1):161] | PubMed: 40374605 |
| LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation [ Cell Discov, 2025, 11(1):84] | PubMed: 41162356 |
| Silencing PCSK9 reshapes the spatiotemporal activation of STING for safe and effective cancer immunotherapy [ Nat Commun, 2025, 10.1038/s41467-025-66630-x] | PubMed: 41290746 |
| Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity [ Nat Commun, 2025, 16(1):3546] | PubMed: 40229277 |
| BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma [ Cell Rep Med, 2025, 6(3):101995] | PubMed: 40107246 |
人間や獣医の診断であるか治療的な使用のためにでない。